Habitual is a technology company.
Habitual has raised $430K across 1 funding round.
Key people at Habitual.
Habitual has raised $430K in total across 1 funding round.
Key people at Habitual.
Habitual is a London-based digital health startup founded in 2019 that provides a comprehensive weight management program for individuals with type 2 diabetes, prediabetes, or obesity.[1][2] It combines nutritionally controlled meal replacements, medication-based options, and a behavior change app offering digital coaching, peer support, habit-tracking tools, and personalized lessons rooted in behavioral science, neuroscience, and psychology to drive sustainable weight loss and diabetes remission.[1][2][3][4] The direct-to-consumer service targets self-referring users via weekly or monthly subscriptions, addressing the global obesity crisis and overburdened healthcare systems by enabling medication-free living through long-term habit formation.[1][2] Habitual has raised over £4M ($3M+ USD) across three rounds, achieved profitability in 2025, and plans to expand user growth, team size, and clinical trials.[1][2]
Habitual was founded in September 2019 by co-founders including Napala Pratini (COO), driven by clinical research on nutrition's role in reversing type 2 diabetes and the need for scalable weight management solutions amid rising chronic disease rates.[1][2] The idea emerged from evidence showing nutritionally complete, low-calorie diets combined with habit change could yield sustainable results, prompting a shift from research to a consumer product.[2] It launched publicly in 2021 with diabetes remission programs featuring meal replacements and daily content, later expanding to general weight loss after users without diabetes sought services.[2] Early traction included pre-seed and seed funding, with a pivotal $2.3M (£1.7M) seed round in 2023 led by Atlantic Food Labs, joined by Seedcamp, MMC, and Oxford Seed Fund, bringing total funding to over $3M initially.[1] By 2025, it secured additional capital including an Innovate UK grant, reaching profitability.[2]
Habitual rides the digital health wave targeting chronic diseases like type 2 diabetes and obesity, projected to cost over $1 trillion annually by 2025, accelerated by COVID-19's boost to virtual care and patient demand for lifestyle interventions.[1] Its timing aligns with surging adoption of behavior change apps and personalized nutrition tech, countering healthcare system strains from rising chronic conditions.[1][2] Market forces favoring it include global obesity epidemics, regulatory support for digital therapeutics (e.g., Innovate UK grants), and investor interest in scalable DTC health solutions.[2] Habitual influences the ecosystem by pioneering holistic diabetes remission models, inspiring similar ventures in preventive care and proving profitability in digital health amid economic pressures.[1][2]
Habitual's profitability in 2025 positions it for aggressive scaling, with future funding fueling user acquisition, team expansion, and rigorous clinical trials to validate outcomes and attract partnerships with healthcare providers.[1][2] Trends like AI-enhanced personalization, GLP-1 medication integration, and global telehealth growth will amplify its momentum, potentially expanding beyond diabetes/obesity to broader wellness.[2][4] Its influence may evolve from DTC innovator to ecosystem leader, licensing programs or powering NHS-style integrations, ultimately helping millions reverse chronic conditions in a post-pandemic health paradigm—transforming "Habitual" from a startup name to a verb for sustainable health change.[1][2][3]
Habitual has raised $430K in total across 1 funding round.
Habitual's investors include Balderton Capital, Maki.vc, MMC Ventures, Northzone, Rogue VC, Seedcamp, VTF Capital, Dave Peacock, Nicolas Brusson, Steve Barham, Tim Sadler, Vernon Davis.
Habitual has raised $430K across 1 funding round. Most recently, it raised $430K Seed in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2020 | $430K Seed | Balderton Capital, Maki.vc, MMC Ventures, Northzone, Rogue VC, Seedcamp, VTF Capital, Dave Peacock, Nicolas Brusson, Steve Barham, Tim Sadler, Vernon Davis |
